- Home
- IVDA vs THAR Comparison
IVDA vs THAR Comparison
Compare IVDA & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- THAR
- Stock Information
- Founded
- IVDA 2003
- THAR 2017
- Country
- IVDA United States
- THAR United States
- Employees
- IVDA N/A
- THAR N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- THAR Health Care
- Exchange
- IVDA Nasdaq
- THAR Nasdaq
- Market Cap
- IVDA 6.7M
- THAR 5.5M
- IPO Year
- IVDA N/A
- THAR 2022
- Fundamental
- Price
- IVDA $2.05
- THAR $1.49
- Analyst Decision
- IVDA
- THAR Strong Buy
- Analyst Count
- IVDA 0
- THAR 1
- Target Price
- IVDA N/A
- THAR $17.00
- AVG Volume (30 Days)
- IVDA 85.2K
- THAR 45.3K
- Earning Date
- IVDA 08-13-2025
- THAR 08-08-2025
- Dividend Yield
- IVDA N/A
- THAR N/A
- EPS Growth
- IVDA N/A
- THAR N/A
- EPS
- IVDA N/A
- THAR N/A
- Revenue
- IVDA $7,148,449.00
- THAR N/A
- Revenue This Year
- IVDA $340.48
- THAR N/A
- Revenue Next Year
- IVDA N/A
- THAR N/A
- P/E Ratio
- IVDA N/A
- THAR N/A
- Revenue Growth
- IVDA 54.15
- THAR N/A
- 52 Week Low
- IVDA $1.27
- THAR $0.95
- 52 Week High
- IVDA $8.05
- THAR $6.39
- Technical
- Relative Strength Index (RSI)
- IVDA 44.70
- THAR 41.17
- Support Level
- IVDA $2.22
- THAR $1.60
- Resistance Level
- IVDA $2.58
- THAR $1.75
- Average True Range (ATR)
- IVDA 0.21
- THAR 0.11
- MACD
- IVDA -0.02
- THAR -0.03
- Stochastic Oscillator
- IVDA 5.36
- THAR 0.00
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.